715 related articles for article (PubMed ID: 11295650)
1. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
2. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
3. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
4. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
[TBL] [Abstract][Full Text] [Related]
5. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
[TBL] [Abstract][Full Text] [Related]
6. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
7. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
8. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
LaForce CF; Dockhorn RJ; Findlay SR; Meltzer EO; Nathan RA; Stricker W; Weakley S; Field EA; Rogenes PR
J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
[TBL] [Abstract][Full Text] [Related]
10. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis.
Malmhäll C; Bossios A; Pullerits T; Lötvall J
Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103
[TBL] [Abstract][Full Text] [Related]
11. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
Dahl R; Nielsen LP; Kips J; Foresi A; Cauwenberge P; Tudoric N; Howarth P; Richards DH; Williams M; Pauwels R;
Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
[TBL] [Abstract][Full Text] [Related]
12. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.
Nathan RA; Bronsky EA; Fireman P; Grossman J; LaForce CF; Lemanske RF; Pearlman DS; Ratner PH; Rogenes PR
Ann Allergy; 1991 Sep; 67(3):332-8. PubMed ID: 1897811
[TBL] [Abstract][Full Text] [Related]
13. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
[TBL] [Abstract][Full Text] [Related]
14. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
15. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation.
Godthelp T; Fokkens WJ; Kleinjan A; Holm AF; Mulder PG; Prens EP; Rijntes E
Clin Exp Allergy; 1996 Jun; 26(6):677-88. PubMed ID: 8809425
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
Hallén H; Enerdal J; Graf P
Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
[TBL] [Abstract][Full Text] [Related]
20. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]